M.S. · Doctoral Candidate in Human Development & Family Studies, Penn State
An intervention and prevention scientist studying substance use, opioid use disorder, and the experiences of women involved in the criminal legal system — pairing rigorous qualitative inquiry with quantitative methodology to improve treatment access and mental health care.
Emma Skogseth is a doctoral candidate in Human Development & Family Studies at the Pennsylvania State University, with areas of concentration in Intervention/Prevention Science and Quantitative Methodology. Her work centers the voices of women who use drugs — particularly those involved in the criminal legal system — to understand the barriers they face in accessing medications for opioid use disorder (MOUD) and mental health care.
Drawing on qualitative interviews, mixed-methods evaluation, and quantitative survey design, she translates lived experience into evidence that can inform treatment and policy. She is currently a T32 Prevention and Methodology Training Program Predoctoral Fellow and works in the Addiction, Sex, and Infectious Diseases Lab under the mentorship of Dr. Abenaa Jones and Dr. Max Crowley.
Areas of concentration in Intervention/Prevention Science and Quantitative Methodology. Advisors: Dr. Abenaa Jones & Dr. Max Crowley.
T32 DA017629; MPIs: Maggs, J. & Lanza, S. Advisors: Dr. Abenaa Jones & Dr. Zita Oravecz.
Thesis: Women and Medications for Opioid Use Disorder: Contributors to Treatment Success from the Perspectives of Women in Recovery, Women with Past Attempts in Drug Treatment, and Health and Criminal Justice Professionals.
Honors Thesis: Pandemic Perseverance: An Examination of Perceived Self-Efficacy and COVID-19 Related Stress in Adolescents. Advisor: Dr. Sarah Domoff.
Skogseth, E., Jones, A.A., Quadri, O.H., Dayton, L., & Latkin, C.A. Serious mental illnesses among people who use drugs: Gender differences in prevalence and MOUD treatment in a community-recruited sample.
Skogseth, E., Quadri, O.H., Brant, K., Latkin, C.A., & Jones, A.A. Evaluating changes in mental health across a pilot program of a trauma-informed, gender-specific drug treatment intervention for women: A mixed-methods study.
Jones, A.A., Skogseth, E., Brant, K., Quadri, O.H., & Latkin, C.A. Feasibility and acceptability of a gender-specific and trauma-informed intervention for women who are involved in the criminal-legal system and use drugs.
Jones, A.A., Astemborski, J., Kirk, G., Skogseth, E., & Mehta, S. Spiritual well-being, substance use, and mortality: A prospective cohort study of 869 community-recruited people who inject drugs from 2007–2022.
Quadri, O.H., Jones, A.A., Skogseth, E., & Latkin, C.A. The role of parenting status on drug treatment utilization among people who inject drugs.
Quadri, O.H., Skogseth, E., Brant, K., Apsley, H.B., Latkin, C.A., & Jones, A.A. Between custody and recovery: Parenting and current MOUD use in mothers with criminal legal involvement.
Skogseth, E., Quadri, O.H., Brant, K., Latkin, C.A., & Jones, A.A. Evaluating changes in mental health across a pilot program of a trauma-informed, gender-specific drug treatment intervention for women: A mixed-methods study. ★ Presenter
Quadri, O.H., Skogseth, E., Brant, K., Apsley, H.B., Latkin, C.A., & Jones, A.A. Between custody and recovery: Parenting and current MOUD use in mothers with criminal legal involvement.
Skogseth, E., Quadri, O.H., Brant, K., Latkin, C.A., & Jones, A.A. Evaluating changes in mental health across a pilot program of a trauma-informed, gender-specific drug treatment intervention for women. ★ Presenter
Quadri, O.H., Skogseth, E., Brant, K., Apsley, H.B., Latkin, C.A., & Jones, A.A. Between custody and recovery: Parenting and current MOUD use in mothers with criminal legal involvement.
Skogseth, E., Jones, A.A., Quadri, O.H., Dayton, L., & Latkin, C.A. Serious mental illnesses among people who use drugs: Gender differences in prevalence and MOUD treatment in a community-recruited sample. ★ Presenter
Quadri, O.H., Jones, A.A., Skogseth, E., & Latkin, C.A. The role of parenting status on drug treatment utilization among people who inject drugs.
Skogseth, E., Jones, A.A., Quadri, O.H., Dayton, L., & Latkin, C.A. Serious mental illnesses among people who use drugs: Gender differences in prevalence and MOUD treatment in a community-recruited sample. ★ Presenter
Quadri, O.H., Jones, A.A., Skogseth, E., & Latkin, C.A. The role of parenting status on drug treatment utilization among people who inject drugs.
Jones, A.A., Segel, J., Skogseth, E., Apsley, H., & Santos-Lozada, A.R. Drug overdose deaths among women 1999–2021: Differences by race/ethnicity, age group, and polysubstance use patterns. ★ Speaker & oral session chair
Skogseth, E., Brant, K., Latkin, C., & Jones, A.A. Physical accessibility barriers to medications for opioid use disorder treatment: A qualitative study. ★ Presenter
Quadri, O.H., Skogseth, E., Harrison, E., Brant, K., & Jones, A.A. The role of perceived, enacted, and internalized stigma in the uptake of medications for opioid use disorder among women in the criminal legal system.
Strong-Jones, S., Brant, K., Skogseth, E., Quadri, O.H., & Jones, A.A. Mental health care barriers for women involved in the criminal legal system with substance use disorders: A qualitative study.
Skogseth, E., Brant, K., Latkin, C., & Jones, A.A. Physical accessibility barriers to medications for opioid use disorder treatment: A qualitative study. ★ Presenter
Quadri, O.H., Skogseth, E., Harrison, E., Brant, K., & Jones, A.A. The role of perceived, enacted, and internalized stigma in the uptake of medications for opioid use disorder among women in the criminal legal system.
Skogseth, E., Brant, K., Harrison, E., Apsley, H.B., Crowley, M., Schwartz, R.P., & Jones, A.A. Women and medications for opioid use disorder: Contributors to treatment success. ★ Presenter
Skogseth, E. & Domoff, S.E. Pandemic perseverance: An examination of perceived self-efficacy and COVID-19 related stress in adolescents. ★ Presenter
Buza, B., Jaster, A., King, D., LaPoint, B., & Skogseth, E. Proposed solutions for accessibility of mental health services at CMHCM. ★ Co-presenter
Open to collaborations, conversations, and questions about substance use research, prevention science, and women's health. The fastest way to reach me is by email.